Doi.org/10.1179/016164111X12881719352570
Jump to navigation
Jump to search
Target Article[edit | edit source]
Clazosentan, a novel endothelin A antagonist, improves cerebral blood flow and behavior after traumatic brain injury. (retraction statement doi: 10.1080/01616412.2017.1288458); Kreipke CW, Rafols JA, Reynolds CA, Schafer S, Marinica A, Bedford C, Fronczak M, Kuhn D, Armstead W; NULL; 2017-5-4; https://doi.org/10.1179/016164111X12881719352570
Reasons[edit | edit source]
Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.